IMPACT OF BODY MASS INDEX ON PROGNOSTIC PREDICTION BY CREATININE-BASED ESTIMATED GLOMERULAR FILTRATION RATE AND CYSTATIN C IN HEART FAILURE  by Matsue, Yuya et al.
Heart Failure
E633
JACC March 12, 2013
Volume 61, Issue 10
impacT of Body mass index on prognosTic predicTion By creaTinine-Based esTimaTed 
glomerular filTraTion raTe and cysTaTin c in hearT failure
Poster Contributions
Poster Sessions, Expo North
Saturday, March 09, 2013, 3:45 p.m.-4:30 p.m.
Session Title: Lessons Learned from Acute Decompensated Heart Failure
Abstract Category: 15. Heart Failure: Clinical
Presentation Number: 1175-284
Authors: Yuya Matsue, Makoto Suzuki, Akihiko Matsumura, Yuji Hashimoto, Kameda Medical Center, Kamogawa, Japan
Background: Estimated glomerular filtration rate by serum creatinine (eGFRCr) is a measure of renal function and is used to predict prognosis 
in heart failure (HF) patients; however, this measure is influenced by some non-renal factors. Cystatin C has emerged as a novel serum measure of 
renal function, and is less affected by muscle mass. Therefore, we hypothesized that body mass index influences the predictive ability of eGFRCr and 
cystatin C for worse prognosis differently in HF patients.
methods: Patients admitted for HF (n = 171) were evaluated using eGFRCr and cystatin C. Cohorts were divided into 3 groups according to tertile 
of BMI (low-, middle-, and high-BMI groups). The endpoint was mortality and/or HF hospitalization, and all cohorts were followed up for median of 
295 days.
results: The mean eGFRCr and cystatin C concentrations were 53.3 ml/min/1.73 m2 and 1.15 mg/L, respectively. Correlation analysis was 
performed between eGFRCr and 1/cystatin c for all cohorts and tertiles, and we found a significant positive correlation between eGFRCr and 1/
cystatin C in all cohorts (r = 0.70, P < 0.001). This significant correlation was observed in all tertiles; however, the correlation was the weakest in 
the low-BMI tertile (r = 0.60, P < 0.001) compared to that of the middle-BMI (r = 0.73, P < 0.001) and high-BMI groups (r = 0.74, P < 0.001). 
In receiver operating characteristic curve analysis, area under the curve (AUC) for predicting worse prognosis was not significantly different in 
the middle- (0.77 vs. 0.78, P = 0.74) and high-BMI groups (0.74 vs. 0.73, P = 0.88). However, in the low-BMI group, the AUC of cystatin C was 
significantly higher than that for eGFRCr for predicting worse prognosis (0.83 vs. 0.66, P = 0.047)
conclusions: Prediction of prognosis in HF patients by cystatin C and eGFRCr is influenced by BMI. Cystatin C may be an important renal function 
indicator of the prediction of prognosis in HF patients, especially in those with low-BMI.
